Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina

被引:16
|
作者
Oros, Sarah M. [1 ,2 ]
Christon, Lillian M. [1 ]
Barth, Kelly S. [1 ]
Berini, Carole R. [3 ]
Padgett, Bennie L. [4 ]
Diaz, Vanessa A. [3 ]
机构
[1] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Internal Med, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Family Med, Charleston, SC 29425 USA
[4] Med Univ South Carolina, Coll Med, Charleston, SC 29425 USA
来源
关键词
opioid use disorder; medication for opioid use disorder; primary care providers barriers; facilitators; internal medicine; family medicine; physician assistant; trainees; QUALITATIVE RESEARCH; UNITED-STATES; BUPRENORPHINE; SUBSTANCE; HEALTH; MANAGEMENT; ALCOHOL; INTERVIEWS; PREVENTION; CRITERIA;
D O I
10.1177/0091217420946240
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective Utilization of medications for opioid use disorder (MOUD) has not been widely adopted by primary care providers. This study sought to identify interprofessional barriers and facilitators for use of MOUD (specifically naltrexone and buprenorphine) among current and future primary care providers in a southeastern academic center in South Carolina. Method Faculty, residents, and students within family medicine, internal medicine, and a physician assistant program participated in focus group interviews, and completed a brief survey. Survey data were analyzed quantitatively, and focus group transcripts were analyzed using a deductive qualitative content analysis, based upon the theory of planned behavior. Results Seven groups (N = 46) completed focus group interviews and surveys. Survey results indicated that general attitudes towards MOUD were positive and did not differ significantly among groups. Subjective norms around prescribing and controllability (i.e., beliefs about whether prescribing was up to them) differed between specialties and between level of training groups. Focus group themes highlighted attitudes about MOUD (e.g., "opens the flood gates" to patients with addiction) and perceived facilitators and barriers of using MOUD in primary care settings. Participants felt that although MOUD in primary care would improve access and reduce stigma for patients, prescribing requires improved provider education and an integrated system of care. Conclusions The results of this study provide an argument for tailoring education to specifically address the barriers primary care prescribers perceive. Results promote the utilization of active, hands-on learning approaches, to ultimately promote uptake of MOUD prescribing in the primary care setting in South Carolina.
引用
收藏
页码:14 / 39
页数:26
相关论文
共 50 条
  • [21] Medications for opioid use disorder in rural primary care practices: Patient and provider experiences
    Bridges, Nora C.
    Taber, Rachel
    Foulds, Abigail L.
    Bear, Todd M.
    Cloutier, Renee M.
    Mcdonough, Brianna L.
    Gordon, Adam J.
    Cochran, Gerald T.
    Donohue, Julie M.
    Adair, Dale
    DiDomenico, Ellen
    Pringle, Janice L.
    Gellad, Walid F.
    Kelley, David
    Cole, Evan S.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 154
  • [22] Knowledge of medications for opioid use disorder and associated stigma among primary care professionals
    Piscalko, Hannah
    Dhanani, Lindsay Y.
    Brook, Daniel
    Hall, O. Trent
    Miller, William C.
    Go, Vivian
    Simon, Janet E.
    Franz, Berkeley
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [23] Primary care for opioid use disorder
    Mannelli, Paolo
    Wu, Li-Tzy
    SUBSTANCE ABUSE AND REHABILITATION, 2016, 7 : 107 - 109
  • [24] Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes
    Banta-Green, Caleb J.
    Owens, Mandy
    Williams, Jason R.
    Floyd, Anthony S.
    Williams-Gilbert, Wendy
    Kingston, Susan
    SUBSTANCE ABUSE AND REHABILITATION, 2024, 15 : 173 - 183
  • [25] The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?
    Meyers, Kathleen
    Herman, Shannon
    Schuler, Heather
    Mun, Carolyn
    Bresani, Elena
    Payne, Richard Koban
    DRUG AND ALCOHOL DEPENDENCE, 2025, 271
  • [26] Breastfeeding Motivators and Barriers in Women Receiving Medications for Opioid Use Disorder
    Yonke, Nicole
    Yakes Jimenez, Elizabeth
    Leeman, Lawrence
    Leyva, Yuridia
    Ortega, Alyssa
    Bakhireva, Ludmila N.
    BREASTFEEDING MEDICINE, 2020, 15 (01) : 17 - 23
  • [27] Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care
    Chen, Joan
    Cabudol, MarkJason
    Williams, Emily C.
    Merrill, Joseph O.
    Tsui, Judith I.
    Klein, Jared W.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 126
  • [28] Drug court utilization of medications for opioid use disorder in high opioid mortality communities
    Marlowe, Douglas B.
    Theiss, David S.
    Ostlie, Erika M.
    Carnevale, John
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 141
  • [29] A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration
    Taylor, Emmeline N.
    Timko, Christine
    Binswanger, Ingrid A.
    Harris, Alex H. S.
    Stimmel, Matthew
    Smelson, David
    Finlay, Andrea K.
    SUBSTANCE ABUSE, 2022, 43 (01) : 556 - 563
  • [30] Medications for Opioid Use Disorder Utilization Among Oxford House Residents
    Majer, John M.
    Jason, Leonard A.
    Norris, Joshua
    Hickey, Patrick
    Jeong, Hayoung
    Bobak, Ted J.
    COMMUNITY MENTAL HEALTH JOURNAL, 2020, 56 (05) : 925 - 932